Mark Perry

Mark L.
Perry is currently a Member at The State Bar of California and a Member at The Association of Bioscience Financial Officers.
Previously, he held positions such as President, Chief Executive Officer & Director at Aerovance, Inc. from 2007 to 2011, Chairman at Pathway Therapeutics, Inc., Director at Nuvelo, Inc. from 2003 to 2009, Director at IntraBiotics Pharmaceuticals, Inc., Lead Independent Director at MyoKardia, Inc. from 2014 to 2020, Independent Director at Global Blood Therapeutics, Inc. from 2015 to 2022, Lead Independent Director at NVIDIA Corp.
from 2018 to 2024, CFO, Executive VP-Operations & General Counsel at Gilead Sciences, Inc. from 1994 to 2004, and Partner at Cooley LLP from 1987 to 1994.
He is also a Member of the California State Bar Association.
Mr. Perry received his undergraduate degree from the University of California, Berkeley and his graduate degree from the University of California, Davis in 1980.